회사 소개
- 법인명: Bioworkshops
- 등록 국가: China
- 주소: No. 5, Dongwang Road,, Suzhou Industrial Park, Suzhou
- 직원 수: 100 - 249
설명:
A full-service CDMO for antibody products, Bioworkshops offers development and cGMP manufacturing of drug substance and final product, including cell line development, process development, analytical methods, formulation, and process characterization/validation, with 13,000 liters of single-use cell culture capacity (200L to 2000L), three aseptic filling lines for vials, lyophilized products and prefilled syringes/cartridges up to 100,000 units per batch, along with product testing and CTD dossier support.
사업 활동
바이오의약품
위탁제조업체 (CMO)초기 단계 기업(스타트업)
ATC 분류체계 (해부치료화학분류)
위탁제조업체 (CMO)초기 단계 기업(스타트업)
오리지널 원료의약품
위탁제조업체 (CMO)초기 단계 기업(스타트업)
주요 제품/서비스
- 바이오의약품: Trastuzumab emtansine, Trastuzumab deruxtecan, Bedinvetmab, Benralizumab, Bevacizumab, Burosumab, Camrelizumab, Canakinumab, Casirivimab, Cetuximab, Cilgavimab, Daratumumab, Denosumab, Disitamab Vedotin, Dostarlimab, Dulaglutide, Dupilumab, Durvalumab, Eculizumab, Emicizumab, Erenumab, Etesevimab, Evolocumab, Faricimab, Fremanezumab, Frunevetmab, Galcanezumab, Guselkumab, Hyaluronidase Recombinant Human, Imdevimab, Lanadelumab, Lecanemab, Lokivetmab, Mepolizumab, Nirsevimab, Nivolumab, Ocrelizumab, Ofatumumab, Omalizumab, Palivizumab, Panitumumab, Pembrolizumab, Pertuzumab, Polatuzumab, Ramucirumab, Ranibizumab, Ravulizumab, Recombinant Zoster Vaccine, Risankizumab, Rituximab, Romiplostim, Romosozumab, Sarilumab, Sotatercept-csrk, Tezepelumab, Theralizumab, Tixagevimab & Cilgavimab, Tocilizumab, Trastuzumab, Ustekinumab, Adalimumab, Anifrolumab, Atezolizumab, Bamlanivimab, Bebtelovimab
- 바이오의약품 서비스: Cell Line Development, GMP manufacturing for cell culture products
- ATC 분류체계 (해부치료화학분류): Respiratory Syncytial Virus Vaccine
당사 제품 & 서비스
Sell · Biopharmaceutical Products
인증
증거
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기